21 Million Covid jabs on British soil

The Daily Mail reports today that there is now light at the end of the tunnel for the most at risk groups.

It means that there are enough doses to hit the target of injecting all over 70's, care home residents and health staff by Febuary 15th.

Not all the vaccine consignments have passed regulatory checks and many are yet to be put into vials, but the fact that so many logistical hurdles have been jumped is a major victory in the fight against coronavirus.

Vaccination drive a ray of Hope for World

Pfizer coronavirus jab has stopped 50% of infections in Israel - not just symptoms - raising hopes vaccine will cut transmission of virus.

  • Israel has given first dose of the Pfizer jab to almost 20 percent of its population
  • Preliminary studies show that the vaccine cuts transmission, not just symptoms
  • Expert warned initial studies not enough to conclude transmissions are stopped 
  • Data from hundreds of thousands of people offers extensive view of efficacy
  • But experts have warned that people must stay vigilant despite having first dose
  • Two other studies were also done, with varying results. One found the vaccine cuts infection risk by 60 percent, while another found it was cut by 33 percent
  • Full 95 percent immunity is only achieved when a person is given second dose

Initial studies of data from Israel's vaccination drive suggest that the first dose of the Pfizer jab curbs coronavirus infections by up to 50 percent after 14 days.

The news offers a ray of hope to the rest of the world as initial studies point to the vaccine not only stopping symptoms, but cutting the risk of infection as well.

With Israel rolling out the world's fastest vaccination programme, giving the first dose to almost 20 percent of its population, studies of hundreds of thousands of people offer perhaps the most extensive real-world data on the vaccine's efficacy.

But Dr. Sharon Alroy-Preis, head of the Health Ministry's public health department, stressed to Israel's Channel 12 that the research was preliminary, and highlighted the need for caution - even among those that have received the first dose of jab.

Alroy-Preis noted that the data was not enough to conclude that the vaccine stops transmission of Covid-19, because it is believed that a person can still spread the virus to others for a limited time if it is still located in their nasal cavity.


Source: https://www.dailymail.co.uk/news/article-9146189/Israel-vaccine-60.html